<VariationArchive RecordType="classified" VariationID="17571" VariationName="NM_004364.5(CEBPA):c.211_214dup (p.Ala72fs)" VariationType="Duplication" Accession="VCV000017571" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-02-13" DateCreated="2017-05-01" MostRecentSubmission="2017-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32610" VariationID="17571">
      <GeneList>
        <Gene Symbol="CEBPA" FullName="CCAAT enhancer binding protein alpha" GeneID="1050" HGNC_ID="HGNC:1833" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="33299934" stop="33302534" display_start="33299934" display_stop="33302534" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="33790839" stop="33793429" display_start="33790839" display_stop="33793429" Strand="-" />
          </Location>
          <OMIM>116897</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CEBPA">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CEBPA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004364.5(CEBPA):c.211_214dup (p.Ala72fs)</Name>
      <CanonicalSPDI>NC_000019.10:33302200:CGGCCGG:CGGCCGGCCGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="33302200" stop="33302201" display_start="33302200" display_stop="33302201" variantLength="4" positionVCF="33302200" referenceAlleleVCF="G" alternateAlleleVCF="GCGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="33793106" stop="33793107" display_start="33793106" display_stop="33793107" variantLength="4" positionVCF="33793106" referenceAlleleVCF="G" alternateAlleleVCF="GCGGC" />
      </Location>
      <ProteinChange>A107fs</ProteinChange>
      <ProteinChange>A58fs</ProteinChange>
      <ProteinChange>A72fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_456" sequenceAccession="LRG_456">
            <Expression>LRG_456:g.5321_5324dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.33302204_33302207dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.33302204_33302207dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.33793110_33793113dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.33793110_33793113dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012022.1" sequenceAccession="NG_012022" sequenceVersion="1" change="g.5321_5324dup">
            <Expression>NG_012022.1:g.5321_5324dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001285829.2" sequenceAccession="NM_001285829" sequenceVersion="2" change="c.-147_-144dup">
            <Expression>NM_001285829.2:c.-147_-144dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287424.2" sequenceAccession="NM_001287424" sequenceVersion="2" change="c.316_319dup">
            <Expression>NM_001287424.2:c.316_319dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274353.1" sequenceAccession="NP_001274353" sequenceVersion="1" change="p.Ala107fs">
            <Expression>NP_001274353.1:p.Ala107fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287435.2" sequenceAccession="NM_001287435" sequenceVersion="2" change="c.169_172dup">
            <Expression>NM_001287435.2:c.169_172dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274364.1" sequenceAccession="NP_001274364" sequenceVersion="1" change="p.Ala58fs">
            <Expression>NP_001274364.1:p.Ala58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004364.5" sequenceAccession="NM_004364" sequenceVersion="5" change="c.211_214dup" MANESelect="true">
            <Expression>NM_004364.5:c.211_214dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004355.2" sequenceAccession="NP_004355" sequenceVersion="2" change="p.Ala72fs">
            <Expression>NP_004355.2:p.Ala72fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA280239" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="116897.0006" DB="OMIM" />
        <XRef Type="rs" ID="587776849" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed PMID 12661007 Fig. 2C to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004364.5(CEBPA):c.211_214dup (p.Ala72fs) AND Acute myeloid leukemia" Accession="RCV000019131" Version="7">
        <ClassifiedConditionList TraitSetID="6288">
          <ClassifiedCondition DB="MedGen" ID="C0023467">Acute myeloid leukemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-05-01" MostRecentSubmission="2017-05-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12661007</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6288" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myelogenous, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018874" DB="MONDO" />
                <XRef ID="519" DB="Orphanet" />
                <XRef ID="17788007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myeloid, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myeloid leukemia, adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AML adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myelogenous leukemia</ElementValue>
                <XRef ID="Acute+Myeloid+Leukemia%2C+Adult/204" DB="Genetic Alliance" />
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute non-lymphocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute granulocytic leukemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AML</ElementValue>
                <XRef ID="GTR000500636" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="601626" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CEBPA-associated familial acute myeloid leukemia (AML) is defined as the presence of a heterozygous germline CEBPA pathogenic variant in an individual with AML and/or family in which more than one individual has AML. In contrast, sporadic CEBPA-associated AML is defined as AML in which a CEBPA pathogenic variant(s) is identified in leukemic cells but not in the non-leukemic cells. In the majority of individuals, the age of onset of familial AML appears to be earlier than sporadic AML; disease onset has been reported in persons as young as age 1.8 years and up to age 50 years. The prognosis of CEBPA-associated familial AML appears to be favorable compared with sporadic CEBPA-associated AML. Individuals with CEBPA-associated familial AML who have been cured of their initial disease may be at greater risk of developing additional independent leukemic episodes, in addition to the risk of relapse from preexisting clones.</Attribute>
                <XRef ID="NBK47457" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">Constitutively activated FLT3</Attribute>
                <XRef ID="GTR000552464" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20963938</ID>
                <ID Source="BookShelf">NBK47457</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ESMO, 2013">
                <ID Source="PubMed">23970018</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33226740</ID>
                <ID Source="BookShelf">NBK564234</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ESMO, 2020">
                <ID Source="PubMed">32171751</ID>
              </Citation>
              <XRef ID="519" DB="Orphanet" />
              <XRef ID="C0023467" DB="MedGen" />
              <XRef ID="D015470" DB="MeSH" />
              <XRef ID="MONDO:0018874" DB="MONDO" />
              <XRef Type="MIM" ID="601626" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004808" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001914" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004843" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005516" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006724" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006728" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39419" SubmissionDate="2017-04-28" DateLastUpdated="2017-05-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="116897.0006_LEUKEMIA, ACUTE MYELOID, SOMATIC" title="CEBPA, 4-BP INS, 363GGCC_LEUKEMIA, ACUTE MYELOID, SOMATIC" />
        <ClinVarAccession Accession="SCV000039419" DateUpdated="2017-05-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the somatic 4-bp insertion (363_364insGGCC) in the CEBPA gene that was found in compound heterozygous state in a patient with acute myeloid leukemia (601626) of the M1 subtype by Snaddon et al. (2003), see 116897.0005.</Attribute>
              <Citation>
                <ID Source="PubMed">12661007</ID>
              </Citation>
              <XRef DB="OMIM" ID="601626" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEBPA" />
          </GeneList>
          <Name>CEBPA, 4-BP INS, 363GGCC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 363GGCC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="116897.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LEUKEMIA, ACUTE MYELOID, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39419" TraitType="Disease" MappingType="Name" MappingValue="LEUKEMIA, ACUTE MYELOID, SOMATIC" MappingRef="Preferred">
        <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

